BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2013
View Archived Issues
Ventria Bioscience and USC receive grant for fusion protein
Read More
Researchers develop potential treatment for Batten disease
Read More
Daiichi Sankyo to form new company to pursue treatment for DMD
Read More
Otsuka Pharmaceutical offers overview of third quarter of fiscal 2012
Read More
Phase II trial of tenecteplase in patients with minor stroke begins
Read More
ARN-509 demonstrates activity in different prostate cancer populations
Read More
Oramed Pharmaceuticals gives update on IND for oral insulin
Read More
Auris Medical completes enrollment in phase II AM-101 study
Read More
Vanderbilt University and GSK to develop novel treatments for severe obesity
Read More
Bristol-Myers Squibb presents results of the phase III READY trial in mCRPC
Read More
Verastem seeks orphan drug status for VS-6063 in mesothelioma
Read More
German researchers present new matrix metalloproteinase inhibitors
Read More
Novo Nordisk discloses novel monoclonal antibodies
Read More
Teva Pharmaceutical Industries synthesizes novel IL-17RA mutants
Read More
First-in-human results presented for AMG-208 in patients with advanced solid tumors
Read More
Lycus synthesizes novel melatonin receptor ligands
Read More
New tyrosine-protein kinase inhibitors patented by Boehringer Ingelheim
Read More
Novartis discloses new agents for macular degeneration
Read More
In vitro investigation of the signaling pathways of a novel antimitotic estradiol analogue
Read More
VENICE trial shows no improvement in overall survival for aflibercept
Read More
New disintegrating tablet formulation of Diovan approved in Japan
Read More
Hexvix indication expanded in Europe
Read More
FDA accepts resubmission of oral treprostinil NDA
Read More
BioAlliance Pharma to extend phase II trial of Validive to the U.S.
Read More
Novo Nordisk launches NovoSeven pre-filled syringe for bleeding control in Europe and U.S.
Read More
St George's and Orphan Technologies sign agreement to develop new therapies for metabolic disorders
Read More
